ongoing trials in polycythemia vera: low-pv & verify
Published 2 years ago • 484 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:30
the verify trial: rusfertide in patients with polycythemia vera
-
1:56
rationale for verify: rusfertide added to ongoing therapy in patients with polycythemia vera
-
2:08
phase iii trial of rusfertide in patients with polycythemia vera
-
3:10
promising trials in polycythemia vera
-
1:12
contemporary challenges in polycythemia vera management
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
3:12
diagnosed early in life with polycythemia vera: todd’s mpn story
-
4:59
behind the mystery, polycythemia vera
-
2:38
ongoing data from the phase 3 response trial of ruxolitinib for polycythemia vera
-
10:20
new guidelines for the treatment and management of polycythemia vera
-
2:16
determining when to switch from hydroxyurea to interferon-based therapy in patients with pv
-
3:07
the current treatment algorithm for polycythemia vera
-
2:14
the role of bmt & clinical trials in patients with pv with multiple treatment-limiting toxicities
-
1:04
promising agents under investigation in polycythemia vera
-
2:05
ropeg in polycythemia vera: long-term proud-pv and conti-pv results
-
2:55
pv-aim: using machine learning to predict resistance to hydroxyurea therapy in patients with pv
-
1:39
upcoming agents in et and pv
-
3:02
current and emerging management strategies in polycythemia vera
-
2:54
an update on the use of idasanutlin in polycythemia vera
-
3:10
the stories behind the advances in polycythemia vera
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
1:35
pv-pinpoint: a study investigating the diagnosis and management of polycythemia vera in the uk